Sartorius (OTCMKTS:SARTF) Sees Significant Drop in Short Interest

Sartorius (OTCMKTS:SARTF – Get Free Report) was the target of a large decline in short interest in October. As of October 30th, there was short interest totaling 836 shares, a decline of 54.2% from the October 15th total of 1,827 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ? days. Currently, 0.0% of the shares of the stock are short sold.

Sartorius Stock Performance

SARTF stock remained flat at $261.99 during mid-day trading on Friday. Sartorius has a 12-month low of $181.58 and a 12-month high of $261.99. The firm has a fifty day moving average price of $241.61 and a 200-day moving average price of $224.03. The stock has a market cap of $8.97 billion, a P/E ratio of 121.85 and a beta of 0.98. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.95 and a quick ratio of 0.49.

About Sartorius

(Get Free Report)

Sartorius is a life science company headquartered in Göttingen, Germany. Founded in 1870 as a precision-balance manufacturer, it has grown into a global supplier of technologies and services for biopharmaceutical production and laboratory research. The company’s bioprocessing products include filtration and fluid-management systems, single-use equipment, bioreactors, and technologies used in cell culture and purification. These solutions support the development and manufacture of biologic medicines, including vaccines and other advanced therapies.

Further Reading

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.